OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A highly attenuated vaccinia virus strain LC16m8-based vaccine for severe fever with thrombocytopenia syndrome
Tomoki Yoshikawa, Satoshi Taniguchi, Hirofumi Kato, et al.
PLoS Pathogens (2021) Vol. 17, Iss. 2, pp. e1008859-e1008859
Open Access | Times Cited: 32

Showing 1-25 of 32 citing articles:

High body temperature increases gut microbiota-dependent host resistance to influenza A virus and SARS-CoV-2 infection
Minami Nagai, Miyu Moriyama, Chiharu Ishii, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 34

Current Progress of Severe Fever with Thrombocytopenia Syndrome Virus (SFTSV) Vaccine Development
Do-Kyun Kim, Chih‐Jen Lai, In‐Ho Cha, et al.
Viruses (2024) Vol. 16, Iss. 1, pp. 128-128
Open Access | Times Cited: 10

Emerging Tick-Borne Dabie bandavirus: Virology, Epidemiology, and Prevention
Eun-Ha Kim, Su‐Jin Park
Microorganisms (2023) Vol. 11, Iss. 9, pp. 2309-2309
Open Access | Times Cited: 22

The Tick-Borne Pathogens: An Overview of China’s Situation
Yuxuan Luan, Jing-min Gou, Dongjie Zhong, et al.
Acta Parasitologica (2023) Vol. 68, Iss. 1, pp. 1-20
Open Access | Times Cited: 18

Animal Model of Severe Fever With Thrombocytopenia Syndrome Virus Infection
Jiawen Sun, Yuan‐Qin Min, Yunjie Li, et al.
Frontiers in Microbiology (2022) Vol. 12
Open Access | Times Cited: 25

The Adaptive Immune Response against Bunyavirales
Reem Alatrash, Bobby Brooke Herrera
Viruses (2024) Vol. 16, Iss. 3, pp. 483-483
Open Access | Times Cited: 5

Monkeypox: potential vaccine development strategies
José Manuel Lozano, Sylviane Muller
Trends in Pharmacological Sciences (2022) Vol. 44, Iss. 1, pp. 15-19
Open Access | Times Cited: 21

Development of a novel multi-epitope mRNA vaccine candidate to combat SFTSV pandemic
Fei Zhu, Shiyang Ma, Yizhong Xu, et al.
PLoS neglected tropical diseases (2025) Vol. 19, Iss. 1, pp. e0012815-e0012815
Open Access

AAV-based vectors for human diseases modeling in laboratory animals
Timur I. Aliev, Dmitry V. Yudkin
Frontiers in Medicine (2025) Vol. 11
Open Access

A broadly protective antibody targeting glycoprotein Gn inhibits severe fever with thrombocytopenia syndrome virus infection
Xuanxiu Ren, Jiawen Sun, Wenhua Kuang, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 3

Vaccine Development for Severe Fever with Thrombocytopenia Syndrome
Tomoki Yoshikawa
Viruses (2021) Vol. 13, Iss. 4, pp. 627-627
Open Access | Times Cited: 23

Recent Advances in the Study of the Immune Escape Mechanism of SFTSV and Its Therapeutic Agents
Lei Chen, Tingting Chen, Ruidong Li, et al.
Viruses (2023) Vol. 15, Iss. 4, pp. 940-940
Open Access | Times Cited: 9

Two Point Mutations in the Glycoprotein of SFTSV Enhance the Propagation Recombinant Vesicular Stomatitis Virus Vectors at Assembly Step
Qiang Hu, Yuhang Zhang, Jia-Fu Jiang, et al.
Viruses (2023) Vol. 15, Iss. 3, pp. 800-800
Open Access | Times Cited: 6

A replication-competent smallpox vaccine LC16m8Δ-based COVID-19 vaccine
Akihiko Sakamoto, Hiroaki Osawa, Hinata Hashimoto, et al.
Emerging Microbes & Infections (2022) Vol. 11, Iss. 1, pp. 2359-2370
Open Access | Times Cited: 9

Screening of a Small Molecule Compound Library Identifies Toosendanin as an Inhibitor Against Bunyavirus and SARS-CoV-2
Shufen Li, Meidi Ye, Yuanqiao Chen, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 12

Third-generation smallpox vaccine strain-based recombinant vaccines for viral hemorrhagic fevers
Tomoki Yoshikawa
Vaccine (2021) Vol. 39, Iss. 41, pp. 6174-6181
Closed Access | Times Cited: 11

Development and evaluation of a mouse model susceptible to severe fever with thrombocytopenia syndrome virus by rAAV-based exogenous human DC-SIGN expression
Ji-Young Park, Chandran Sivasankar, Chamith Hewawaduge, et al.
Microbial Pathogenesis (2023) Vol. 178, pp. 106079-106079
Closed Access | Times Cited: 4

Construction of a recombinant vaccine expressing Nipah virus glycoprotein using the replicative and highly attenuated vaccinia virus strain LC16m8
Shumpei Watanabe, Tomoki Yoshikawa, Yoshihiro Kaku, et al.
PLoS neglected tropical diseases (2023) Vol. 17, Iss. 12, pp. e0011851-e0011851
Open Access | Times Cited: 4

The Adaptive Immune Response against Bunyaviruses
Reem Alatrash, Bobby Brooke Herrera
(2024)
Open Access | Times Cited: 1

Comparative analysis of the efficacy of vaccines using structural protein subunits of the severe fever with thrombocytopenia syndrome virus
Sohee Kim, Kyeongseok Jeon, Hooncheol Choi, et al.
Frontiers in Microbiology (2024) Vol. 15
Open Access | Times Cited: 1

Vaccine Development for Severe Fever with Thrombocytopenia Syndrome Virus in Dogs
Seok‐Chan Park, Daeun Jeong, Sun-Woo Han, et al.
The Journal of Microbiology (2024) Vol. 62, Iss. 4, pp. 327-335
Closed Access | Times Cited: 1

Recent research advances in the development of Dabie Banda virus vaccines
Chenyang Yu, Yuxiang Lin, Yixin Dai, et al.
PLoS neglected tropical diseases (2024) Vol. 18, Iss. 8, pp. e0012411-e0012411
Open Access | Times Cited: 1

Severe Fever with Thrombocytopenia Syndrome, a Viral Hemorrhagic Fever, Endemic to Japan: Achievements in and Directions for Medical Research
Masayuki Saijo
Japanese Journal of Infectious Diseases (2022) Vol. 75, Iss. 3, pp. 217-227
Open Access | Times Cited: 6

Page 1 - Next Page

Scroll to top